A detailed history of Aegon Asset Management Uk PLC transactions in Abb Vie Inc. stock. As of the latest transaction made, Aegon Asset Management Uk PLC holds 490,323 shares of ABBV stock, worth $96.5 Million. This represents 1.18% of its overall portfolio holdings.

Number of Shares
490,323
Previous 429,672 14.12%
Holding current value
$96.5 Million
Previous $78.1 Million 7.34%
% of portfolio
1.18%
Previous 1.17%

Shares

23 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 30, 2024

BUY
$154.79 - $180.76 $9.39 Million - $11 Million
60,651 Added 14.12%
490,323 $83.9 Million
Q1 2024

Apr 18, 2024

BUY
$159.82 - $182.1 $63.9 Million - $72.8 Million
400,030 Added 1349.54%
429,672 $78.1 Million
Q4 2023

Jan 11, 2024

BUY
$137.6 - $154.97 $767,395 - $864,267
5,577 Added 23.17%
29,642 $4.59 Million
Q2 2023

Jul 28, 2023

SELL
$132.51 - $164.9 $471,735 - $587,044
-3,560 Reduced 12.89%
24,065 $3.24 Million
Q1 2023

Apr 14, 2023

SELL
$144.61 - $166.54 $443,808 - $511,111
-3,069 Reduced 10.0%
27,625 $4.4 Million
Q4 2022

Oct 19, 2023

BUY
$138.31 - $165.87 $916,856 - $1.1 Million
6,629 Added 27.55%
30,694 $4.96 Million
Q4 2022

Jan 17, 2023

BUY
$138.31 - $165.87 $909,526 - $1.09 Million
6,576 Added 27.27%
30,694 $4.96 Million
Q3 2022

Oct 18, 2022

SELL
$134.21 - $153.93 $200,643 - $230,125
-1,495 Reduced 5.84%
24,118 $3.24 Million
Q2 2022

Jul 12, 2022

SELL
$137.62 - $174.96 $137,482 - $174,785
-999 Reduced 3.75%
25,613 $3.93 Million
Q1 2022

Apr 28, 2022

SELL
$131.98 - $163.75 $862,621 - $1.07 Million
-6,536 Reduced 19.72%
26,612 $4.31 Million
Q4 2021

Jan 24, 2022

BUY
$107.43 - $135.93 $78,961 - $99,908
735 Added 2.27%
33,148 $4.49 Million
Q3 2021

Oct 28, 2021

SELL
$106.4 - $120.78 $510,507 - $579,502
-4,798 Reduced 12.89%
32,413 $3.5 Million
Q1 2021

May 07, 2021

SELL
$102.3 - $112.62 $159,588 - $175,687
-1,560 Reduced 4.02%
37,211 $4.03 Million
Q3 2020

Oct 30, 2020

BUY
$85.91 - $100.83 $762,193 - $894,563
8,872 Added 29.67%
38,771 $3.39 Million
Q2 2020

Aug 06, 2020

BUY
$73.37 - $98.18 $1.17 Million - $1.57 Million
15,995 Added 115.04%
29,899 $2.93 Million
Q1 2020

Apr 30, 2020

BUY
$64.5 - $97.79 $896,808 - $1.36 Million
13,904 New
13,904 $1.06 Million
Q1 2019

Apr 10, 2019

SELL
$77.14 - $90.79 $6.36 Million - $7.49 Million
-82,507 Closed
0 $0
Q4 2018

Jan 14, 2019

SELL
$77.85 - $96.01 $20.6 Million - $25.4 Million
-264,803 Reduced 76.24%
82,507 $7.61 Million
Q3 2018

Oct 11, 2018

SELL
$88.91 - $98.84 $9.63 Million - $10.7 Million
-108,316 Reduced 23.77%
347,310 $32.9 Million
Q2 2018

Jul 10, 2018

BUY
$89.78 - $106.23 $9.35 Million - $11.1 Million
104,165 Added 29.64%
455,626 $42.2 Million
Q1 2018

May 09, 2018

BUY
$92.01 - $123.21 $4.11 Million - $5.5 Million
44,628 Added 14.54%
351,461 $33.1 Million
Q4 2017

Jan 12, 2018

SELL
$89.56 - $98.21 $133,175 - $146,038
-1,487 Reduced 0.48%
306,833 $29.7 Million
Q3 2017

Nov 08, 2017

BUY
$69.85 - $89.22 $21.5 Million - $27.5 Million
308,320
308,320 $27.4 Million

Others Institutions Holding ABBV

About AbbVie Inc.


  • Ticker ABBV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,768,099,968
  • Market Cap $348B
  • Description
  • AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...
More about ABBV
Track This Portfolio

Track Aegon Asset Management Uk PLC Portfolio

Follow Aegon Asset Management Uk PLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Aegon Asset Management Uk PLC, based on Form 13F filings with the SEC.

News

Stay updated on Aegon Asset Management Uk PLC with notifications on news.